How many benefit plans does Theravance Biopharma U.S., Inc. report on Form 5500?

Theravance Biopharma U.S., Inc. (EIN 46-3451245) reports 2 benefit plan(s) in the loaded Form 5500 dataset.

What is the EIN for Theravance Biopharma U.S., Inc.?

The Employer Identification Number (EIN) reported for Theravance Biopharma U.S., Inc. is 46-3451245.

What is the latest Form 5500 filing year for Theravance Biopharma U.S., Inc.?

The latest loaded Form 5500 filing year for Theravance Biopharma U.S., Inc. is 2023.

Theravance Biopharma U.S., Inc. — Form 5500 filings & benefit plans

Form 5500 plan sponsor summary

According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Theravance Biopharma U.S., Inc. (EIN 46-3451245) is a plan sponsor located in South San Francisco, CA with 2 reported benefit plan(s) in the loaded dataset. The latest loaded Form 5500 filing year is 2023.

Company overview (based on loaded 2023 public filings)

EIN: 46-3451245
Location: South San Francisco, CA
Loaded plans: 2
Latest filing year: 2023

Reported financial aggregate (2023)

Reported net position

Total reported assets (EOY): $75,157,740
Total reported liabilities (EOY): $0
Total reported net assets (EOY): $75,157,740

Contributions & income

Employer contributions: $478,215
Participant contributions: $2,208,907
Total income / additions: $15,499,778

Expenses & distributions

Benefits paid / distributions: $6,250,791
Total expenses: $6,276,603
Net increase / (decrease): $9,223,175

Coverage

Total reported participants: 553
Plans with financial statements: 1
Plans with provider compensation: 1

Totals sum the latest loaded 2023 public Form 5500 filing per plan for this company's plans — one filing per plan, so multiple years are never double-counted. Figures are reported values from loaded Schedule H / I (and Schedule C for provider compensation); fields a plan did not report are treated as missing, not zero. These are not audited or official totals.

Largest loaded plans by reported assets

Theravance Biopharma U.S., Inc. plans by reported end-of-year assets
Plan	Plan #	Participants	Reported assets (EOY)	Year
Theravance Biopharma U.S., Inc. 401(K) Plan	001	430	$75,157,740	2023
Theravance Biopharma Us, Inc. Health And Welfare Plan	503	123	not reported in the loaded dataset	2023

Search all 2 loaded plans for this company →

Latest loaded filings

Most recent loaded Form 5500 filings for Theravance Biopharma U.S., Inc.
Year	Plan	Participants	Schedules	Filing
2023	Theravance Biopharma U.S., Inc. 401(K) Plan	430	H, C	20240805081043NAL0002833714001
2023	Theravance Biopharma Us, Inc. Health And Welfare Plan	123	—	20250130151915NAL0000949665001